Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity
PDB DOI: 10.2210/pdb9kgq/pdb
Classification: HYDROLASE/INHIBITOR Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct
Deposited: 2024-11-08 Deposition Author(s): Baburajendran, N.
Discovery of an orally bioavailable reversible covalent sars-cov-2 mpro inhibitor with pan-coronavirus activity
Primary Citation of Related Structures: 9KGQ
Proteins | ||||
---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Sequence |
3C-like proteinase nsp5 | B | 311 | Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct | GPLGSSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ |
3C-like proteinase nsp5 | A | 311 | Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct | GPLGSSGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ |
compound 4 | C | 4 | Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct | XVLX |
compound 4 | D | 4 | Severe Acute Respiratory Syndrome Coronavirus 2 , Synthetic Construct | XVLX |
Method: X-RAY DIFFRACTION
Deposited Date: 2024-11-08 Deposition Author(s): Baburajendran, N.